ADARx Pharmaceuticals prices $446.3M IPO at $17 per share

2 sources ·5 articles ·3h ago ADARx Pharmaceuticals

2 outlets - including Investing and Bloomberg - are covering this story. Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering that priced at the top of its marketed range.

Covered by 2 outlets

Investing 4 Bloomberg 1

All coverage · 5 articles

Investing.com Canada ·3h ago

Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO

Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering that priced at the top of its marketed range.

Investing.com UK ·3h ago

ADARx Pharmaceuticals prices $446.3M IPO at $17 per share